8 results
Insulin Comparison Chart

Insulin Types - Onset (hours) - Peak Glycemic Effect (hours) - Duration (hours)
 •
Insulin Comparison ... Chart Insulin ... #Comparison #Table ... #pharmacology # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... daily dose of insulin ... #Medications #pharmacology ... #comparison #table ... #endocrinology
FIASP - Insulin Aspart vs Novolog

Have you heard about Fiasp, a new version of insulin aspart
FIASP - Insulin ... Fiasp is insulin ... control and can also cause ... #Pharmacology # ... EBM #Endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... glucose-dependent insulin ... Ozempic), or daily tablet ... not definitively cause ... DM2 #diabetes #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... agent • Does not cause ... #Metformin #Pharmacology ... DM2 #diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Januvia) - Once/day tablet ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
Concentrated Insulin

Developed with the goal of easing therapy by reducing the volume & number of injections
Concentrated Insulin ... injections and in some cases ... Large volumes insulin ... decreased volumes & frequency ... #pharmacology #
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
been reported to cause ... are listed in Table ... to be the most frequent ... cause of drug-induced ... #Pharmacology #Drugs